Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis
Pharmaceuticals · 07.03.2024 · 17 (3) · 347
DOI: 10.3390/ph17030347 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 07.03.2024. Verfasst von Francesca Bernardi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, 20132 Milan, Italy. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In recent years, there has been a growing focus on the intricate interplay between the gut microbiota and host health, specifically in the context of inflammatory bowel diseases (IBDs). The gut microbiota produces a diverse array of metabolites, influencing the host’s immune response and tissue homeostasis. Noteworthy metabolites, such as short-chain fatty acids, bile acids, and indoles, exert significant effects on intestinal inflammation and fibrosis. This review integrates current research findings to clarify the mechanisms through which gut microbiota metabolites contribute to the progression of IBD and fibrosis, offering insights into potential therapeutic targets and strategies for managing these intricate gastrointestinal conditions. The unraveling of the complex relationship between gut microbiota metabolites and inflammatory processes holds promise for the development of targeted interventions that could lead to more effective and personalized treatment approaches for individuals affected by IBD and subsequent intestinal fibrosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, 20132 Milan, Italy.
ORCID-Profile: Ferdinando D'Amico, Sarah Bencardino, Federica Furfaro
Zitieren
APA
Bernardi, F., D'Amico, F., Bencardino, S., Faggiani, I., Fanizza, J., Zilli, A., Parigi, T. L., Allocca, M., Danese, S., & Furfaro, F. (2024). Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis. Pharmaceuticals, 17(3), 347. https://doi.org/10.3390/ph17030347
Vancouver
Bernardi F, D'Amico F, Bencardino S, Faggiani I, Fanizza J, Zilli A, et al. Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis. Pharmaceuticals. 2024;17(3):347. doi:10.3390/ph17030347
BibTeX
@article{Bernardi2024,
author = {Bernardi, Francesca and D'Amico, Ferdinando and Bencardino, Sarah and Faggiani, Ilaria and Fanizza, Jacopo and Zilli, Alessandra and Parigi, Tommaso Lorenzo and Allocca, Mariangela and Danese, Silvio and Furfaro, Federica},
title = {Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {3},
pages = {347},
doi = {10.3390/ph17030347}
}
EUVIMED